Correlation of Immunological and Histopathological Features with Gene Expression-Based Classifiers in Colon Cancer Patients

Autor: Weerd, S. van de, Smit, M.A., Roelands, J., Mesker, W.E., Bedognetti, D., Kuppen, P.J.K., Putter, H., Tollenaar, R.A.E.M., Roodhart, J.M.L., Hendrickx, W., Medema, J.P., Krieken, J.H.J.M. van

Publikováno v: International journal of molecular sciences, 23(20):12707. Multidisciplinary Digital Publishing Institute (MDPI)
International Journal of Molecular Sciences, 23, 20
International Journal of Molecular Sciences, 23
International Journal of Molecular Sciences; Volume 23; Issue 20; Pages: 12707
International Journal of Molecular Sciences, 23(20). MDPI

The purpose of this study was to evaluate the association between four distinct histopathological features: (1) tumor infiltrating lymphocytes, (2) mucinous differentiation, (3) tumor-stroma ratio, plus (4) tumor budding and two gene expression-based

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13f2813a2686f8b353f4ea6ec9c86a64
https://pure.amc.nl/en/publications/correlation-of-immunological-and-histopathological-features-with-gene-expressionbased-classifiers-in-colon-cancer-patients(f068674f-5c61-42ec-952a-a748eb4490ba).html

Systems biology as a compass to understand cancer-immune interactions in humans

Autor: Roelands, J.

Publikováno v: None

Major achievements in the field of immune oncology have demonstrated the ability of the immune system to induce a response against cancer. The prognostic impact of pre-existing immunity in several cancer types, including breast and colon cancer, demo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::2e2eb623f5e1ed780b501286223a1931
https://hdl.handle.net/1887/3420985

Proceedings From the First International Workshop at Sidra Medicine:'Engineered Immune Cells in Cancer Immunotherapy (EICCI): From Discovery to Off-the-Shelf Development', 15th–16th February 2019, Doha, Qatar

Autor: Guerrouahen B., Elnaggar M., Al-Mohannadi A., Kizhakayil D., Bonini C., Benjamin R., Brentjens R., Buchholz C. J., Casorati G., Ferrone S., Locke F. L., Martin F., Schambach A., Turtle C., Veys P., van der Vliet H. J., Maccalli C., Benabdellah K., Bos T., Cugno C., Johnston I., Mohamed A., Ponterio E., Abu Rasheed H. M., Roelands J., Taha R. Y.

Publikováno v: The EICCI Faculty Group 2021, ' Proceedings From the First International Workshop at Sidra Medicine : “Engineered Immune Cells in Cancer Immunotherapy (EICCI): From Discovery to Off-the-Shelf Development”, 15th–16th February 2019, Doha, Qatar ', Frontiers in Immunology, vol. 11, 589381 . https://doi.org/10.3389/fimmu.2020.589381
Digibug. Repositorio Institucional de la Universidad de Granada
instname
Digibug: Repositorio Institucional de la Universidad de Granada
Universidad de Granada (UGR)
Frontiers in immunology, 11:589381
Frontiers in Immunology, Vol 11 (2021)
Frontiers in Immunology

The progress in the isolation and characterization of tumor antigen (TA)-specific T lymphocytes and in the genetic modification of immune cells allowed the clinical development of adoptive cell therapy (ACT). Several clinical studies highlighted the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e31d5dca100c7285451baaf17f735ef9
https://research.vumc.nl/en/publications/0d3f3ecb-ab4b-401d-ad6a-70f0a6c59ca6

Annexin A3 in sepsis

Autor: Toufiq, M., Roelands, J., Alfaki, M., Kabeer, B.S.A., Saadaoui, M., Lakshmanan, A.P., Bangarusamy, D.K., Murugesan, S., Bedognetti, D., Hendrickx, W., Khodor, S. al, Terranegra, A., Rinchai, D., Chaussabel, D., Garand, M.

According to publicly available transcriptome datasets, the abundance of Annexin A3 (ANXA3) is robustly increased during the course of sepsis; however, no studies have examined the biological significance or clinical relevance of ANXA3 in this pathol

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______202::6a13863ca506a22e70e25d591e303ce7
https://hdl.handle.net/1887/3627018

339P Molecular subtyping for chemotherapy response prediction in early stage colon cancer

Autor: van de Weerd, S., Torang, A., Smit, M., van den Berg, I., Roelands, J., Mesker, W., Bedognetti, D., Kuppen, P., Putter, H., Tollenaar, R.A.E.M., Hendrickx, W.R.L., Jimenez, C., Vink, G., Koopman, M., Roodhart, J., Ijzermans, J., van Krieken, H., Medema, J-P.

Publikováno v: In Annals of Oncology September 2022 33 Supplement 7:S691-S692